{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:39:11Z","timestamp":1790793551986,"version":"4.1.0"},"reference-count":154,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2016,8,9]],"date-time":"2016-08-09T00:00:00Z","timestamp":1470700800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"},{"start":{"date-parts":[[2016,8,9]],"date-time":"2016-08-09T00:00:00Z","timestamp":1470700800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med. Res. Rev."],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1002\/med.21403","type":"journal-article","created":{"date-parts":[[2016,8,9]],"date-time":"2016-08-09T06:49:13Z","timestamp":1470725353000},"page":"52-97","source":"Crossref","is-referenced-by-count":126,"title":["Applications of Polymers as Pharmaceutical Excipients in Solid Oral Dosage Forms"],"prefix":"10.1002","volume":"37","author":[{"given":"Nir","family":"Debotton","sequence":"first","affiliation":[{"name":"Department of Chemical Engineering; Shenkar College of Engineering and Design; Ramat-Gan Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arik","family":"Dahan","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, School of Pharmacy, Faculty of Health Sciences; Ben-Gurion University of the Negev; Beer-Sheva Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,8,9]]},"reference":[{"key":"10.1002\/med.21403-BIB0001|med21403-cit-0001","unstructured":"Convention USP USP35 NF30 2012 U. S. Pharmacopoeia National Formulary Rockville: United States Pharmacopeial"},{"key":"10.1002\/med.21403-BIB0002|med21403-cit-0002","first-page":"1","volume-title":"Guidance for Industry Nonclinical Studies for the Safety Evaluation of Pharmaceutical Excipients","author":"FDA","year":"2005"},{"issue":"3","key":"10.1002\/med.21403-BIB0003|med21403-cit-0003","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrd3028","article-title":"Membrane transporters in drug development","volume":"9","author":"Giacomini","year":"2010","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"10.1002\/med.21403-BIB0004|med21403-cit-0004","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11095-004-9004-4","article-title":"Predicting drug disposition via application of BCS: Transport\/absorption\/elimination interplay and development of a biopharmaceutics drug disposition classification system","volume":"22","author":"Wu","year":"2005","journal-title":"Pharm Res"},{"issue":"6","key":"10.1002\/med.21403-BIB0005|med21403-cit-0005","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.addr.2007.08.043","article-title":"Predicting drug disposition, absorption\/elimination\/transporter interplay and the role of food on drug absorption","volume":"60","author":"Custodio","year":"2008","journal-title":"Adv Drug Deliv Rev"},{"issue":"7","key":"10.1002\/med.21403-BIB0006|med21403-cit-0006","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1021\/mp300104s","article-title":"A win-win solution in oral delivery of lipophilic drugs: Supersaturation via amorphous solid dispersions increases apparent solubility without sacrifice of intestinal membrane permeability","volume":"9","author":"Miller","year":"2012","journal-title":"Mol Pharm"},{"issue":"4","key":"10.1002\/med.21403-BIB0007|med21403-cit-0007","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1021\/mp100050d","article-title":"Enabling the intestinal absorption of highly polar antiviral agents: Ion-pair facilitated membrane permeation of zanamivir heptyl ester and guanidino oseltamivir","volume":"7","author":"Miller","year":"2010","journal-title":"Mol Pharm"},{"issue":"3","key":"10.1002\/med.21403-BIB0008|med21403-cit-0008","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.ejpb.2013.12.008","article-title":"Development of pressure-sensitive dosage forms with a core liquefying at body temperature","volume":"86","author":"Wilde","year":"2014","journal-title":"Eur J Pharm Biopharm"},{"issue":"10","key":"10.1002\/med.21403-BIB0009|med21403-cit-0009","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1002\/jps.2600541027","article-title":"Physical and chemical stability testing of tablet dosage forms","volume":"54","author":"Lachman","year":"1965","journal-title":"J Pharm Sci"},{"issue":"3","key":"10.1002\/med.21403-BIB0010|med21403-cit-0010","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1023\/A:1016212804288","article-title":"A theoretical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability","volume":"12","author":"Amidon","year":"1995","journal-title":"Pharm Res"},{"issue":"6","key":"10.1002\/med.21403-BIB0011|med21403-cit-0011","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1021\/mp300140h","article-title":"The fraction dose absorbed, in humans, and high jejunal human permeability relationship","volume":"9","author":"Dahan","year":"2012","journal-title":"Mol Pharm"},{"issue":"3, Part B","key":"10.1002\/med.21403-BIB0012|med21403-cit-0012","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.ejpb.2013.05.018","article-title":"The interaction of nifedipine with selected cyclodextrins and the subsequent solubility-permeability trade-off","volume":"85","author":"Beig","year":"2013","journal-title":"Eur J Pharm Biopharm"},{"issue":"2","key":"10.1002\/med.21403-BIB0013|med21403-cit-0013","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1208\/s12248-012-9337-6","article-title":"The solubility-permeability interplay and its implications in formulation design and development for poorly soluble drugs","volume":"14","author":"Dahan","year":"2012","journal-title":"AAPS J"},{"issue":"2-3","key":"10.1002\/med.21403-BIB0014|med21403-cit-0014","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jconrel.2005.08.024","article-title":"Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine","volume":"108","author":"Tanaka","year":"2005","journal-title":"J Control Release"},{"issue":"4-5","key":"10.1002\/med.21403-BIB0015|med21403-cit-0015","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.ejps.2012.12.030","article-title":"Mechanistic modelling of drug release from a polymer matrix using magnetic resonance microimaging","volume":"48","author":"Kaunisto","year":"2013","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"10.1002\/med.21403-BIB0016|med21403-cit-0016","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3109\/10717544.2010.509365","article-title":"Physicochemical characterization and in vivo evaluation of flurbiprofen-loaded solid dispersion without crystalline change","volume":"18","author":"Oh","year":"2011","journal-title":"Drug Deliv"},{"issue":"7","key":"10.1002\/med.21403-BIB0017|med21403-cit-0017","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1021\/acs.molpharmaceut.5b00202","article-title":"Dissolution and solubility enhancement of the highly lipophilic drug phenytoin via interaction with poly(N-isopropylacrylamide-co-vinylpyrrolidone) excipients","volume":"12","author":"Widanapathirana","year":"2015","journal-title":"Mol Pharm"},{"issue":"7","key":"10.1002\/med.21403-BIB0018|med21403-cit-0018","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1007\/s11095-011-0386-9","article-title":"Effects of food on a gastrically degraded drug: Azithromycin fast-dissolving gelatin capsules and HPMC capsules","volume":"28","author":"Curatolo","year":"2011","journal-title":"Pharm Res"},{"issue":"5","key":"10.1002\/med.21403-BIB0019|med21403-cit-0019","first-page":"269","article-title":"Development of an osmotic pump system for controlled delivery of diclofenac sodium","volume":"6","author":"Emara","year":"2012","journal-title":"Drug Discov Ther"},{"issue":"6","key":"10.1002\/med.21403-BIB0020|med21403-cit-0020","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3109\/10837450.2013.823990","article-title":"Controlled porosity osmotic pump system for the delivery of diclofenac sodium: In-vitro and in-vivo evaluation","volume":"19","author":"Emara","year":"2014","journal-title":"Pharm Dev Technol"},{"issue":"2","key":"10.1002\/med.21403-BIB0021|med21403-cit-0021","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3109\/10611869509059209","article-title":"Preparation and evaluation of a time-controlled release capsule made of ethylcellulose for colon delivery of drugs","volume":"3","author":"Niwa","year":"1995","journal-title":"J Drug Target"},{"issue":"1-3","key":"10.1002\/med.21403-BIB0022|med21403-cit-0022","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0168-3659(97)00123-5","article-title":"Importance of dissolution process on systemic availability of drugs delivered by colon delivery system","volume":"50","author":"Takaya","year":"1998","journal-title":"J Control Release"},{"key":"10.1002\/med.21403-BIB0023|med21403-cit-0023","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ejps.2015.06.020","article-title":"Application of physiologically based pharmacokinetic modeling in the prediction of pharmacokinetics of bicyclol controlled-release formulation in human","volume":"77","author":"Wang","year":"2015","journal-title":"Eur J Pharm Sci"},{"issue":"Suppl 1","key":"10.1002\/med.21403-BIB0024|med21403-cit-0024","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.nano.2012.07.005","article-title":"Polymeric particulate technologies for oral drug delivery and targeting: A pathophysiological perspective","volume":"8","author":"Hunter","year":"2012","journal-title":"Nanomedicine"},{"issue":"4","key":"10.1002\/med.21403-BIB0025|med21403-cit-0025","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s40262-015-0242-x","article-title":"Oral bioavailability: Issues and solutions via nanoformulations","volume":"54","author":"Pathak","year":"2015","journal-title":"Clin Pharmacokinet"},{"key":"10.1002\/med.21403-BIB0026|med21403-cit-0026","volume-title":"The Science and Practice of Pharmacy, 20th Edition","author":"Troy","year":"2006"},{"key":"10.1002\/med.21403-BIB0027|med21403-cit-0027","volume-title":"Pharmaceutical Dosage Forms: Tablets","volume":"1","author":"Lieberman","year":"1989"},{"issue":"1-2","key":"10.1002\/med.21403-BIB0028|med21403-cit-0028","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ijpharm.2004.04.015","article-title":"A novel powder coating process for attaining taste masking and moisture protective films applied to tablets","volume":"279","author":"Cerea","year":"2004","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1002\/med.21403-BIB0029|med21403-cit-0029","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.colsurfb.2011.04.007","article-title":"Development and evaluation of orally disintegrating tablets (ODTs) containing Ibuprofen granules prepared by hot melt extrusion","volume":"86","author":"Gryczke","year":"2011","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"1-2","key":"10.1002\/med.21403-BIB0030|med21403-cit-0030","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ijpharm.2013.07.072","article-title":"In vitro and in vivo correlation of disintegration and bitter taste masking using orally disintegrating tablet containing ion exchange resin-drug complex","volume":"455","author":"Kim","year":"2013","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1002\/med.21403-BIB0031|med21403-cit-0031","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0939-6411(98)00087-3","article-title":"Dry coating: An innovative enteric coating method using a cellulose derivative","volume":"47","author":"Obara","year":"1999","journal-title":"Eur J Pharm Biopharm"},{"issue":"8","key":"10.1002\/med.21403-BIB0032|med21403-cit-0032","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1081\/DDC-120024188","article-title":"Pharmaceutical applications of shellac: Moisture-protective and taste-masking coatings and extended-release matrix tablets","volume":"29","author":"Pearnchob","year":"2003","journal-title":"Drug Dev Ind Pharm"},{"issue":"1","key":"10.1002\/med.21403-BIB0033|med21403-cit-0033","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ejpb.2009.05.006","article-title":"Strongly enhanced dissolution rate of fenofibrate solid dispersion tablets by incorporation of superdisintegrants","volume":"73","author":"Srinarong","year":"2009","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"10.1002\/med.21403-BIB0034|med21403-cit-0034","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0939-6411(98)00086-1","article-title":"Influence of aqueous coatings on the stability of enteric coated pellets and tablets","volume":"47","author":"Thoma","year":"1999","journal-title":"Eur J Pharm Biopharm"},{"issue":"3 Pt B","key":"10.1002\/med.21403-BIB0035|med21403-cit-0035","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.ejpb.2013.05.002","article-title":"Stability and repeatability of a continuous twin screw granulation and drying system","volume":"85","author":"Vercruysse","year":"2013","journal-title":"Eur J Pharm Biopharm"},{"issue":"11","key":"10.1002\/med.21403-BIB0036|med21403-cit-0036","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1002\/jps.20679","article-title":"Influence of solid phase and formulation processing on stability of Abbott-232 tablet formulations","volume":"95","author":"Wardrop","year":"2006","journal-title":"J Pharm Sci"},{"issue":"6","key":"10.1002\/med.21403-BIB0037|med21403-cit-0037","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.addr.2007.09.009","article-title":"Challenges and opportunities in the encapsulation of liquid and semi-solid formulations into capsules for oral administration","volume":"60","author":"Cole","year":"2008","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"10.1002\/med.21403-BIB0038|med21403-cit-0038","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0378-5173(87)90172-4","article-title":"Importance of drug type, tablet shape and added diluents on drug release kinetics from hydroxypropylmethylcellulose matrix tablets","volume":"40","author":"Ford","year":"1987","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1002\/med.21403-BIB0039|med21403-cit-0039","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0168-3659(98)00110-2","article-title":"Influence of drug:hydroxypropylmethylcellulose ratio, drug and polymer particle size and compression force on the release of diclofenac sodium from HPMC tablets","volume":"57","author":"Velasco","year":"1999","journal-title":"J Control Release"},{"issue":"7","key":"10.1002\/med.21403-BIB0040|med21403-cit-0040","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1080\/03639040500216360","article-title":"Role of cellulose ether polymers on ibuprofen release from matrix tablets","volume":"31","author":"Vueba","year":"2005","journal-title":"Drug Dev Ind Pharm"},{"issue":"5","key":"10.1002\/med.21403-BIB0041|med21403-cit-0041","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/jps.2600800514","article-title":"Effect of formulation solubility and hygroscopicity on disintegrant efficiency in tablets prepared by wet granulation, in terms of dissolution","volume":"80","author":"Johnson","year":"1991","journal-title":"J Pharm Sci"},{"key":"10.1002\/med.21403-BIB0042|med21403-cit-0042","volume-title":"Pharmaceutical Dosage Forms-Tablets","author":"Augsburger","year":"2008"},{"issue":"2","key":"10.1002\/med.21403-BIB0043|med21403-cit-0043","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/jps.21429","article-title":"Characterization of moisture-protective polymer coatings using differential scanning calorimetry and dynamic vapor sorption","volume":"98","author":"Bley","year":"2009","journal-title":"J Pharm Sci"},{"key":"10.1002\/med.21403-BIB0044|med21403-cit-0044","volume-title":"Handbook of Pharmaceutical Excipients","author":"Rowe","year":"2009"},{"issue":"1-2","key":"10.1002\/med.21403-BIB0045|med21403-cit-0045","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ijpharm.2013.11.020","article-title":"Distribution of a viscous binder during high shear granulation-sensitivity to the method of delivery and its impact on product properties","volume":"460","author":"Tan","year":"2014","journal-title":"Int J Pharm"},{"issue":"10","key":"10.1002\/med.21403-BIB0046|med21403-cit-0046","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1081\/DDC-100102279","article-title":"Investigating the fundamental effects of binders on pharmaceutical tablet performance","volume":"25","author":"Joneja","year":"1999","journal-title":"Drug Dev Ind Pharm"},{"issue":"1","key":"10.1002\/med.21403-BIB0047|med21403-cit-0047","first-page":"12","article-title":"Effect of various binding agents on tablet hardness and release rate profiles of diclofenac sodium tablets","volume":"3","author":"Nadadivya","year":"2012","journal-title":"Int J Res Pharm Sci"},{"issue":"3","key":"10.1002\/med.21403-BIB0048|med21403-cit-0048","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0378-5173(91)90417-M","article-title":"Moisture adsorption and tabletting. III. Effect on tablet strenght-post compaction storage time profiles","volume":"73","author":"Alderborn","year":"1991","journal-title":"Int J Pharm"},{"issue":"4","key":"10.1002\/med.21403-BIB0049|med21403-cit-0049","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1023\/A:1007549625317","article-title":"Effect of the storage conditions on the tensile strength of tablets in relation to the enthalpy relaxation of the binder","volume":"17","author":"Kiekens","year":"2000","journal-title":"Pharm Res"},{"issue":"9","key":"10.1002\/med.21403-BIB0050|med21403-cit-0050","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1002\/jps.24303","article-title":"Oral solid dosage form dsintegration testing-the forgotten test","volume":"104","author":"Al-Gousous","year":"2015","journal-title":"J Pharm Sci"},{"issue":"1","key":"10.1002\/med.21403-BIB0051|med21403-cit-0051","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2013.03.012","article-title":"An easy-to-use approach for determining the disintegration ability of disintegrants by analysis of available surface area","volume":"448","author":"Iwao","year":"2013","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1002\/med.21403-BIB0052|med21403-cit-0052","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/jps.2600610244","article-title":"Mechanism of action of tablet disintegrants: Correlation of tablet mean pore diameter and porosity","volume":"61","author":"Lowenthal","year":"1972","journal-title":"J Pharm Sci"},{"issue":"9","key":"10.1002\/med.21403-BIB0053|med21403-cit-0053","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1002\/jps.2600600907","article-title":"Mechanism of action of starch as a tablet disintegrant IV: Effect of medicaments and disintegrants on mean pore diameter and porosity","volume":"60","author":"Lowenthal","year":"1971","journal-title":"J Pharm Sci"},{"issue":"8","key":"10.1002\/med.21403-BIB0054|med21403-cit-0054","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1002\/jps.2600650810","article-title":"Effect of intragranular and extragranular disintegrating agents on particle size of disintegrated tablets","volume":"65","author":"Shotton","year":"1976","journal-title":"J Pharm Sci"},{"issue":"1","key":"10.1002\/med.21403-BIB0055|med21403-cit-0055","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1208\/s12249-011-9717-8","article-title":"Effect of sorbed water on disintegrant performance of four brands of Polacrilin Potassium NF","volume":"13","author":"Bele","year":"2012","journal-title":"AAPS PharmSciTech"},{"key":"10.1002\/med.21403-BIB0056|med21403-cit-0056","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ejpb.2015.05.028","article-title":"Enhanced physical stabilization of fenofibrate nanosuspensions via wet co-milling with a superdisintegrant and an adsorbing polymer","volume":"94","author":"Azad","year":"2015","journal-title":"Eur J Pharm Biopharm"},{"issue":"2","key":"10.1002\/med.21403-BIB0057|med21403-cit-0057","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/jps.2600820222","article-title":"Effect of the mode of super disintegrant incorporation on dissolution in wet granulated tablets","volume":"82","author":"Gordon","year":"1993","journal-title":"J Pharm Sci"},{"issue":"7","key":"10.1002\/med.21403-BIB0058|med21403-cit-0058","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/jps.2600830702","article-title":"Cross-linking of gelatin capsules and its relevance to their in vitro-in vivo performance","volume":"83","author":"Digenis","year":"1994","journal-title":"J Pharm Sci"},{"issue":"6","key":"10.1002\/med.21403-BIB0059|med21403-cit-0059","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1208\/s12249-014-0162-3","article-title":"Enzymes in the dissolution testing of gelatin capsules","volume":"15","author":"Marques","year":"2014","journal-title":"AAPS PharmSciTech"},{"issue":"8","key":"10.1002\/med.21403-BIB0060|med21403-cit-0060","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/jps.2600760811","article-title":"Multiple tamping effects on drug dissolution from capsules filled on a dosing-disk type automatic capsule filling machine","volume":"76","author":"Shah","year":"1987","journal-title":"J Pharm Sci"},{"issue":"5","key":"10.1002\/med.21403-BIB0061|med21403-cit-0061","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1023\/B:PHAM.0000026430.73789.e6","article-title":"In vitro and in vivo pharmacoscintigraphic evaluation of ibuprofen hypromellose and gelatin capsules","volume":"21","author":"Cole","year":"2004","journal-title":"Pharm Res"},{"issue":"1","key":"10.1002\/med.21403-BIB0062|med21403-cit-0062","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0378-5173(01)00871-7","article-title":"Enteric coated HPMC capsules designed to achieve intestinal targeting","volume":"231","author":"Cole","year":"2002","journal-title":"Int J Pharm"},{"key":"10.1002\/med.21403-BIB0063|med21403-cit-0063","first-page":"1","volume-title":"ICH Topic Q 6 A","author":"European Medicines Agency","year":"2000"},{"key":"10.1002\/med.21403-BIB0064|med21403-cit-0064","volume-title":"CDER Data Standards Manual (C-DRG-00201 Version 008)","author":"FDA","year":"2006"},{"key":"10.1002\/med.21403-BIB0065|med21403-cit-0065","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0022-4804(64)80040-8","article-title":"The use of silicone rubber as a carrier for prolonged drug therapy","volume":"4","author":"Folkman","year":"1964","journal-title":"J Surg Res"},{"issue":"3","key":"10.1002\/med.21403-BIB0066|med21403-cit-0066","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jconrel.2006.05.004","article-title":"A model for the drug release from a polymer matrix tablet-effects of swelling and dissolution","volume":"113","author":"Borgquist","year":"2006","journal-title":"J Control Release"},{"issue":"12","key":"10.1002\/med.21403-BIB0067|med21403-cit-0067","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1002\/jps.2600641218","article-title":"Elementary osmotic pump","volume":"64","author":"Theeuwes","year":"1975","journal-title":"J Pharm Sci"},{"key":"10.1002\/med.21403-BIB0068|med21403-cit-0068","volume-title":"BEIJING UNION PHARMACEUTICAL FACTORY, assignee. Double-layer osmotic pump controlled release tablet of bicyclol and preparation method thereof patent EP2471521 A1","author":"Guo","year":"2012"},{"issue":"3","key":"10.1002\/med.21403-BIB0069|med21403-cit-0069","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1208\/s12249-014-0246-0","article-title":"Controlled porosity solubility modulated osmotic pump tablets of gliclazide","volume":"16","author":"Banerjee","year":"2015","journal-title":"AAPS PharmSciTech"},{"issue":"2","key":"10.1002\/med.21403-BIB0070|med21403-cit-0070","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/10717540802586220","article-title":"Development and release mechanism of diltiazem HCl prolonged release matrix tablets","volume":"16","author":"Boyapally","year":"2009","journal-title":"Drug Deliv"},{"issue":"3","key":"10.1002\/med.21403-BIB0071|med21403-cit-0071","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1023\/A:1014447102710","article-title":"Understanding and predicting drug delivery from hydrophilic matrix tablets using the \u201csequential layer\u201d model","volume":"19","author":"Siepmann","year":"2002","journal-title":"Pharm Res"},{"issue":"8","key":"10.1002\/med.21403-BIB0072|med21403-cit-0072","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1002\/jps.23632","article-title":"Elucidation of release characteristics of highly soluble drug trimetazidine hydrochloride from chitosan-carrageenan matrix tablets","volume":"102","author":"Li","year":"2013","journal-title":"J Pharm Sci"},{"issue":"10","key":"10.1002\/med.21403-BIB0073|med21403-cit-0073","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/jps.2600811005","article-title":"Relationship of film properties to drug release from monolithic films containing adjuvants","volume":"81","author":"Jenquin","year":"1992","journal-title":"J Pharm Sci"},{"issue":"4","key":"10.1002\/med.21403-BIB0074|med21403-cit-0074","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/10717540500459308","article-title":"Preparation and characterization of metoprolol controlled-release solid dispersions","volume":"13","author":"Varshosaz","year":"2006","journal-title":"Drug Deliv"},{"key":"10.1002\/med.21403-BIB0075|med21403-cit-0075","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.ejpb.2015.07.027","article-title":"A flexible-dose dispenser for immediate and extended release 3D printed tablets","volume":"96","author":"Pietrzak","year":"2015","journal-title":"Eur J Pharm Biopharm"},{"issue":"9","key":"10.1002\/med.21403-BIB0076|med21403-cit-0076","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1248\/cpb.50.1181","article-title":"Evaluation of the disintegration time of rapidly disintegrating tablets via a novel method utilizing a CCD camera","volume":"50","author":"Morita","year":"2002","journal-title":"Chem Pharm Bull"},{"issue":"3","key":"10.1002\/med.21403-BIB0077|med21403-cit-0077","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0928-0987(02)00011-8","article-title":"Fast dispersible ibuprofen tablets","volume":"15","author":"Schiermeier","year":"2002","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"10.1002\/med.21403-BIB0078|med21403-cit-0078","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/jps.24262","article-title":"The effects of screw configuration and polymeric carriers on hot-melt extruded taste-masked formulations incorporated into orally disintegrating tablets","volume":"104","author":"Morott","year":"2015","journal-title":"J Pharm Sci"},{"key":"10.1002\/med.21403-BIB0079|med21403-cit-0079","first-page":"489","volume-title":"Pharmaceutical Coating Technology","author":"Graham","year":"1995"},{"issue":"5","key":"10.1002\/med.21403-BIB0080|med21403-cit-0080","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1208\/s12249-014-0128-5","article-title":"Application of ethylcellulose coating to hydrophilic matrices: A strategy to modulate drug release profile and reduce drug release variability","volume":"15","author":"Mehta","year":"2014","journal-title":"AAPS PharmSciTech"},{"issue":"2","key":"10.1002\/med.21403-BIB0081|med21403-cit-0081","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1208\/s12248-013-9462-x","article-title":"Regional-dependent intestinal Permeability and BCS classification: Elucidation of pH-related complexity in rats using pseudoephedrine","volume":"15","author":"Fairstein","year":"2013","journal-title":"AAPS J"},{"issue":"61","key":"10.1002\/med.21403-BIB0082|med21403-cit-0082","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejps.2013.11.007","article-title":"The complexity of intestinal permeability: Assigning the correct BCS classification through careful data interpretation","volume":"30","author":"Zur","year":"2014","journal-title":"Eur J Pharm Sci"},{"issue":"9","key":"10.1002\/med.21403-BIB0083|med21403-cit-0083","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1002\/jps.24274","article-title":"Investigation of pH and temperature profiles in the GI tract of fasted human subjects using the intellicap\u00ae system","volume":"104","author":"Koziolek","year":"2015","journal-title":"J Pharm Sci"},{"issue":"5","key":"10.1002\/med.21403-BIB0084|med21403-cit-0084","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1021\/mp100175a","article-title":"High-permeability criterion for BCS classification: Segmental\/pH dependent permeability considerations","volume":"7","author":"Dahan","year":"2010","journal-title":"Mol Pharm"},{"issue":"7","key":"10.1002\/med.21403-BIB0085|med21403-cit-0085","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1023\/A:1015827908309","article-title":"Upper gastrointestinal (GI) pH in young, healthy men and women","volume":"7","author":"Dressman","year":"1990","journal-title":"Pharm Res"},{"issue":"8","key":"10.1002\/med.21403-BIB0086|med21403-cit-0086","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1136\/gut.29.8.1035","article-title":"Measurement of gastrointestinal pH profiles in normal ambulant human subjects","volume":"29","author":"Evans","year":"1988","journal-title":"Gut"},{"issue":"5","key":"10.1002\/med.21403-BIB0087|med21403-cit-0087","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1021\/mp100149j","article-title":"Physiological parameters for oral delivery and in vitro testing","volume":"7","author":"Mudie","year":"2010","journal-title":"Mol Pharm"},{"key":"10.1002\/med.21403-BIB0088|med21403-cit-0088","unstructured":"Min DS Um KA Kim YS Park PW Sunkyong Industries Co., Ltd., assignee Method for preparing enteric-coated oral drugs containing acid-unstable compounds patent 1995"},{"issue":"4","key":"10.1002\/med.21403-BIB0089|med21403-cit-0089","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1510\/icvts.2007.155788","article-title":"Does enteric-coated aspirin result in a lower incidence of gastrointestinal complications compared to normal aspirin","volume":"6","author":"Walker","year":"2007","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"1-2","key":"10.1002\/med.21403-BIB0090|med21403-cit-0090","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ijpharm.2014.04.019","article-title":"Accelerating the dissolution of enteric coatings in the upper small intestine: Evolution of a novel pH 5.6 bicarbonate buffer system to assess drug release","volume":"468","author":"Varum","year":"2014","journal-title":"Int J Pharm"},{"issue":"12","key":"10.1002\/med.21403-BIB0091|med21403-cit-0091","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1081\/DDC-100102305","article-title":"Basic coating polymers for the colon-specific drug delivery in inflammatory bowel disease","volume":"26","author":"Leopold","year":"2000","journal-title":"Drug Dev Ind Pharm"},{"issue":"4","key":"10.1002\/med.21403-BIB0092|med21403-cit-0092","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1586\/eci.10.30","article-title":"Drug targeting strategies for the treatment of inflammatory bowel disease: A mechanistic update","volume":"6","author":"Dahan","year":"2010","journal-title":"Expert Rev Clin Immunol"},{"issue":"10","key":"10.1002\/med.21403-BIB0093|med21403-cit-0093","doi-asserted-by":"crossref","first-page":"16489","DOI":"10.3390\/molecules191016489","article-title":"Modern prodrug design for targeted oral drug delivery","volume":"19","author":"Dahan","year":"2014","journal-title":"Molecules"},{"issue":"9","key":"10.1002\/med.21403-BIB0094|med21403-cit-0094","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1517\/17425247.2013.800480","article-title":"New targeting strategies in drug therapy of inflammatory bowel disease: Mechanistic approaches and opportunities","volume":"10","author":"Wolk","year":"2013","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1002\/med.21403-BIB0095|med21403-cit-0095","doi-asserted-by":"crossref","DOI":"10.2174\/1568026616666160414122913","article-title":"Phospholipid-based prodrugs for drug targeting in inflammatory bowel disease: Computational optimization and in-vitro correlation","volume":"16","author":"Dahan","year":"2016","journal-title":"Curr Top Med Chem"},{"issue":"1-3","key":"10.1002\/med.21403-BIB0096|med21403-cit-0096","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0378-5173(93)90406-6","article-title":"An in vivo investigation into the suitability of pH dependent polymers for colonic targeting","volume":"95","author":"Ashford","year":"1993","journal-title":"Int J Pharm"},{"issue":"6","key":"10.1002\/med.21403-BIB0097|med21403-cit-0097","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1136\/jcp.37.6.704","article-title":"Colonic bicarbonate output as a test of disease activity in ulcerative colitis","volume":"37","author":"Roediger","year":"1984","journal-title":"J Clin Pathol"},{"issue":"4","key":"10.1002\/med.21403-BIB0098|med21403-cit-0098","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1365-2036.1987.tb00627.x","article-title":"Evaluation of an enteric-coated delayed-release 5-aminosalicylic acid tablet in patients with inflammatory bowel disease","volume":"1","author":"Hardy","year":"1987","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1002\/med.21403-BIB0099|med21403-cit-0099","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0168-3659(98)00151-5","article-title":"A pH-dependent colon targeted oral drug delivery system using methacrylic acid copolymers. I. Manipulation of drug release using Eudragit L100-55 and Eudragit S100 combinations","volume":"58","author":"Khan","year":"1999","journal-title":"J Control Release"},{"issue":"3","key":"10.1002\/med.21403-BIB0100|med21403-cit-0100","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1136\/gutjnl-2012-304258","article-title":"Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: Results from the randomised CORE II study","volume":"63","author":"Travis","year":"2014","journal-title":"Gut"},{"issue":"2","key":"10.1002\/med.21403-BIB0101|med21403-cit-0101","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ejpb.2010.02.012","article-title":"Immersion coating of pellet cores consisting of chitosan and calcium intended for colon drug delivery","volume":"75","author":"Hiorth","year":"2010","journal-title":"Eur J Pharm Biopharm"},{"issue":"4","key":"10.1002\/med.21403-BIB0102|med21403-cit-0102","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1177\/0885328208089617","article-title":"Guar gum as potential film coating material for colon-specific delivery of fluorouracil","volume":"23","author":"Ji","year":"2009","journal-title":"J Biomater Appl"},{"issue":"12","key":"10.1002\/med.21403-BIB0103|med21403-cit-0103","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1111\/j.2042-7158.2010.01165.x","article-title":"Enzymatically degraded Eurylon 6 HP-PG: Ethylcellulose film coatings for colon targeting in inflammatory bowel disease patients","volume":"62","author":"Karrout","year":"2010","journal-title":"J Pharm Pharmacol"},{"issue":"10","key":"10.1002\/med.21403-BIB0104|med21403-cit-0104","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1080\/03639040902858868","article-title":"Characterization of ethylcellulose: Starch-based film coatings for colon targeting","volume":"35","author":"Karrout","year":"2009","journal-title":"Drug Dev Ind Pharm"},{"issue":"1-2","key":"10.1002\/med.21403-BIB0105|med21403-cit-0105","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ijpharm.2008.12.014","article-title":"Novel polymeric film coatings for colon targeting: How to adjust desired membrane properties","volume":"371","author":"Karrout","year":"2009","journal-title":"Int J Pharm"},{"issue":"1-2","key":"10.1002\/med.21403-BIB0106|med21403-cit-0106","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ijpharm.2011.10.045","article-title":"Coated chitosan pellets containing rutin intended for the treatment of inflammatory bowel disease: In vitro characteristics and in vivo evaluation","volume":"422","author":"Rabiskova","year":"2012","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1002\/med.21403-BIB0107|med21403-cit-0107","first-page":"121","article-title":"Pectin\/Ethylcellulose as film coatings for colon-specific drug delivery: Preparation and in vitro evaluation using 5-fluorouracil pellets","volume":"61","author":"Wei","year":"2007","journal-title":"PDA J Pharm Sci Technol"},{"issue":"1","key":"10.1002\/med.21403-BIB0108|med21403-cit-0108","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0378-5173(97)00214-7","article-title":"Investigations into the azo reducing activity of a common colonic microorganism","volume":"157","author":"Bragger","year":"1997","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1002\/med.21403-BIB0109|med21403-cit-0109","doi-asserted-by":"crossref","first-page":"G371","DOI":"10.1152\/ajpgi.00102.2009","article-title":"Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting","volume":"297","author":"Dahan","year":"2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"4768","key":"10.1002\/med.21403-BIB0110|med21403-cit-0110","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1126\/science.3526553","article-title":"A new approach to the oral administration of insulin and other peptide drugs","volume":"233","author":"Saffran","year":"1986","journal-title":"Science"},{"issue":"2","key":"10.1002\/med.21403-BIB0111|med21403-cit-0111","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1023\/A:1016283027139","article-title":"In vivo evaluation of a colon-specific drug delivery system: An absorption study of theophylline from capsules coated with azo polymers in rats","volume":"12","author":"den Mooter","year":"1995","journal-title":"Pharm Res"},{"issue":"2-3","key":"10.1002\/med.21403-BIB0112|med21403-cit-0112","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0168-3659(99)00270-9","article-title":"Linear type azo-containing polyurethane as drug-coating material for colon-specific delivery: Its properties, degradation behavior, and utilization for drug formulation","volume":"66","author":"Yamaoka","year":"2000","journal-title":"J Control Release"},{"issue":"12","key":"10.1002\/med.21403-BIB0113|med21403-cit-0113","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1023\/A:1018911316021","article-title":"The relation between swelling properties and enzymatic degradation of azo polymers designed for colon-specific drug delivery","volume":"11","author":"den Mooter","year":"1994","journal-title":"Pharm Res"},{"issue":"5","key":"10.1002\/med.21403-BIB0114|med21403-cit-0114","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1136\/gut.30.5.634","article-title":"Increased segmental activity and intraluminal pressures in the sigmoid colon of patients with the irritable bowel syndrome","volume":"30","author":"Rogers","year":"1989","journal-title":"Gut"},{"issue":"5","key":"10.1002\/med.21403-BIB0115|med21403-cit-0115","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3109\/1061186X.2010.504264","article-title":"A new pressure-controlled colon delivery capsule for chronotherapeutic treatment of nocturnal asthma","volume":"19","author":"Barakat","year":"2011","journal-title":"J Drug Target"},{"issue":"1-2","key":"10.1002\/med.21403-BIB0116|med21403-cit-0116","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0168-3659(97)00201-0","article-title":"Evaluation of intestinal pressure-controlled colon delivery capsule containing caffeine as a model drug in human volunteers","volume":"52","author":"Muraoka","year":"1998","journal-title":"J Control Release"},{"issue":"5","key":"10.1002\/med.21403-BIB0117|med21403-cit-0117","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1023\/A:1015812615635","article-title":"A simple rheological method for the in vitro assessment of mucin-polymer bioadhesive bond strength","volume":"7","author":"Hassan","year":"1990","journal-title":"Pharm Res"},{"issue":"7","key":"10.1002\/med.21403-BIB0118|med21403-cit-0118","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1023\/A:1012160102740","article-title":"Chitosans as absorption enhancers for poorly absorbable drugs 2: Mechanism of absorption enhancement","volume":"14","author":"Schipper","year":"1997","journal-title":"Pharm Res"},{"issue":"3","key":"10.1002\/med.21403-BIB0119|med21403-cit-0119","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.jconrel.2013.09.004","article-title":"Mucoadhesive intestinal devices for oral delivery of salmon calcitonin","volume":"172","author":"Gupta","year":"2013","journal-title":"J Control Release"},{"issue":"10","key":"10.1002\/med.21403-BIB0120|med21403-cit-0120","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1007\/s11095-011-0489-3","article-title":"Development and in vitro-in vivo evaluation of fenretinide-loaded oral mucoadhesive patches for site-specific chemoprevention of oral cancer","volume":"28","author":"Desai","year":"2011","journal-title":"Pharm Res"},{"issue":"1-2","key":"10.1002\/med.21403-BIB0121|med21403-cit-0121","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0378-5173(96)04613-3","article-title":"Mucoadhesive polymers in peroral peptide drug delivery. V. Effect of poly(acrylates) on the enzymatic degradation of peptide drugs by intestinal brush border membrane vesicles","volume":"141","author":"Lue\u03b2en","year":"1996","journal-title":"Int J Pharm"},{"issue":"4","key":"10.1002\/med.21403-BIB0122|med21403-cit-0122","doi-asserted-by":"crossref","first-page":"416","DOI":"10.2174\/156720111795768004","article-title":"Mucoadhesive patches of Salbutamol sulphate for unidirectional buccal drug delivery: Development and evaluation","volume":"8","author":"Puratchikody","year":"2011","journal-title":"Curr Drug Deliv"},{"issue":"6","key":"10.1002\/med.21403-BIB0123|med21403-cit-0123","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1023\/A:1023803706746","article-title":"Development and in vivo evaluation of an oral delivery system for low molecular weight heparin based on thiolated polycarbophil","volume":"20","author":"Kast","year":"2003","journal-title":"Pharm Res"},{"issue":"2","key":"10.1002\/med.21403-BIB0124|med21403-cit-0124","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0378-5173(03)00271-0","article-title":"Thiolated polymers-thiomers: Synthesis and in vitro evaluation of chitosan-2-iminothiolane conjugates","volume":"260","author":"Bernkop-Schnurch","year":"2003","journal-title":"Int J Pharm"},{"key":"10.1002\/med.21403-BIB0125|med21403-cit-0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.carbpol.2015.01.049","article-title":"Synthesis and in vitro characterization of a novel S-protected thiolated alginate","volume":"124","author":"Hauptstein","year":"2015","journal-title":"Carbohydr Polym"},{"key":"10.1002\/med.21403-BIB0126|med21403-cit-0126","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.actbio.2015.01.020","article-title":"Thiolated silicone oil: Synthesis, gelling and mucoadhesive properties","volume":"16","author":"Partenhauser","year":"2015","journal-title":"Acta Biomater"},{"issue":"4","key":"10.1002\/med.21403-BIB0127|med21403-cit-0127","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1208\/s12248-009-9144-x","article-title":"Prediction of solubility and permeability class membership: Provisional BCS classification of the world's top oral drugs","volume":"11","author":"Dahan","year":"2009","journal-title":"AAPS J"},{"issue":"1","key":"10.1002\/med.21403-BIB0128|med21403-cit-0128","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0939-6411(00)00091-6","article-title":"Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards","volume":"50","author":"Lobenberg","year":"2000","journal-title":"Eur J Pharm Biopharm"},{"issue":"6","key":"10.1002\/med.21403-BIB0129|med21403-cit-0129","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1177\/00970002042006005","article-title":"A mechanistic approach to understanding the factors affecting drug absorption: A review of fundamentals","volume":"42","author":"Martinez","year":"2002","journal-title":"J Clin Pharmacol"},{"issue":"7","key":"10.1002\/med.21403-BIB0130|med21403-cit-0130","doi-asserted-by":"crossref","first-page":"e68237","DOI":"10.1371\/journal.pone.0068237","article-title":"Oral delivery of lipophilic drugs: The tradeoff between solubility increase and permeability decrease when using cyclodextrin-based formulations","volume":"8","author":"Beig","year":"2013","journal-title":"PLoS One"},{"key":"10.1002\/med.21403-BIB0131|med21403-cit-0131","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejps.2015.05.024","article-title":"The use of captisol (SBE7-\u03b2-CD) in oral solubility-enabling formulations: Comparison to HP\u03b2CD and the solubility-permeability interplay","volume":"77","author":"Beig","year":"2015","journal-title":"Eur J Pharm Sci"},{"issue":"2","key":"10.1002\/med.21403-BIB0132|med21403-cit-0132","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.ejpb.2012.02.012","article-title":"Accounting for the solubility-permeability interplay in oral formulation development for poor water solubility drugs: The effect of PEG-400 on carbamazepine absorption","volume":"81","author":"Beig","year":"2012","journal-title":"Eur J Pharm Biopharm"},{"issue":"3","key":"10.1002\/med.21403-BIB0133|med21403-cit-0133","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1021\/mp200460u","article-title":"The solubility-permeability interplay when using cosolvents for solubilization: Revising the way we use solubility-enabling formulations","volume":"9","author":"Miller","year":"2012","journal-title":"Mol Pharm"},{"issue":"5","key":"10.1002\/med.21403-BIB0134|med21403-cit-0134","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1021\/mp200181v","article-title":"The solubility-permeability Interplay: Mechanistic modeling and predictive application of the impact of micellar solubilization on intestinal permeation","volume":"8","author":"Miller","year":"2011","journal-title":"Mol Pharm"},{"issue":"1-2","key":"10.1002\/med.21403-BIB0135|med21403-cit-0135","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.ijpharm.2012.03.017","article-title":"Predicting the solubility-permeability interplay when using cyclodextrins in solubility-enabling formulations: Model validation","volume":"430","author":"Miller","year":"2012","journal-title":"Int J Pharm"},{"issue":"9","key":"10.1002\/med.21403-BIB0136|med21403-cit-0136","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1002\/jps.24496","article-title":"Head-to-head comparison of different solubility-enabling formulations of etoposide and their consequent solubility-permeability interplay","volume":"104","author":"Beig","year":"2015","journal-title":"J Pharm Sci"},{"issue":"2","key":"10.1002\/med.21403-BIB0137|med21403-cit-0137","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1208\/s12248-012-9445-3","article-title":"The twofold advantage of the amorphous form as an oral drug delivery practice for lipophilic compounds: Increased apparent solubility and drug flux through the intestinal membrane","volume":"15","author":"Dahan","year":"2013","journal-title":"AAPS J"},{"key":"10.1002\/med.21403-BIB0138|med21403-cit-0138","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.addr.2016.04.018","article-title":"The solubility-permeability interplay and oral drug formulation design: Two heads are better than one","volume":"101","author":"Dahan","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"10.1002\/med.21403-BIB0139|med21403-cit-0139","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1021\/mp500571m","article-title":"Assessment of the amorphous \u201csolubility\u201d of a group of diverse drugs using new experimental and theoretical approaches","volume":"12","author":"Almeida e Sousa","year":"2015","journal-title":"Mol Pharm"},{"key":"10.1002\/med.21403-BIB0140|med21403-cit-0140","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jconrel.2015.06.027","article-title":"Drug release mechanisms from amorphous solid dispersions","volume":"211","author":"Park","year":"2015","journal-title":"J Control Release"},{"issue":"5","key":"10.1002\/med.21403-BIB0141|med21403-cit-0141","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1021\/acs.molpharmaceut.5b00041","article-title":"Phase separation kinetics in amorphous solid dispersions upon exposure to water","volume":"12","author":"Purohit","year":"2015","journal-title":"Mol Pharm"},{"key":"10.1002\/med.21403-BIB0142|med21403-cit-0142","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jconrel.2015.06.004","article-title":"Probing the mechanisms of drug release from amorphous solid dispersions in medium-soluble and medium-insoluble carriers","volume":"211","author":"Sun","year":"2015","journal-title":"J Control Release"},{"key":"10.1002\/med.21403-BIB0143|med21403-cit-0143","first-page":"1","article-title":"Formulation and pharmacokinetic evaluation of polymeric dispersions containing valsartan","author":"Chella","year":"2015","journal-title":"Eur J Drug Metab Pharmacokinet"},{"issue":"7","key":"10.1002\/med.21403-BIB0144|med21403-cit-0144","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1021\/acs.molpharmaceut.5b00299","article-title":"Crystallization kinetics of indomethacin\/polyethylene glycol dispersions containing high drug loadings","volume":"12","author":"Duong","year":"2015","journal-title":"Mol Pharm"},{"key":"10.1002\/med.21403-BIB0145|med21403-cit-0145","volume-title":"Inactive Ingredient Search for Approved Drug Products","author":"FDA","year":"2016"},{"issue":"1-2","key":"10.1002\/med.21403-BIB0146|med21403-cit-0146","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ijpharm.2005.12.017","article-title":"Elimination of metformin-croscarmellose sodium interaction by competition","volume":"311","author":"Huang","year":"2006","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1002\/med.21403-BIB0147|med21403-cit-0147","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ejps.2007.10.002","article-title":"Interaction between a cationic polymethacrylate (Eudragit E100) and anionic drugs","volume":"33","author":"Quinteros","year":"2008","journal-title":"Eur J Pharm Sci"},{"issue":"8","key":"10.1002\/med.21403-BIB0148|med21403-cit-0148","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1002\/jps.24066","article-title":"A formulation strategy for solving the overgranulation problem in high shear wet granulation","volume":"103","author":"Osei-Yeboah","year":"2014","journal-title":"J Pharm Sci"},{"issue":"12","key":"10.1002\/med.21403-BIB0149|med21403-cit-0149","doi-asserted-by":"crossref","first-page":"4434","DOI":"10.1021\/acs.molpharmaceut.5b00624","article-title":"Mitigation of adverse clinical events of a narrow target therapeutic index compound through modified release formulation design: An in vitro, in vivo, in silico, and clinical pharmacokinetic analysis","volume":"12","author":"Good","year":"2015","journal-title":"Mol Pharm"},{"issue":"9","key":"10.1002\/med.21403-BIB0150|med21403-cit-0150","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/bdd.1819","article-title":"Development of oral extended release formulations of 6-hydroxybuspirone","volume":"33","author":"Nicholson","year":"2012","journal-title":"Biopharm Drug Dispos"},{"key":"10.1002\/med.21403-BIB0151|med21403-cit-0151","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jconrel.2014.09.031","article-title":"Targeting of gastrointestinal tract for amended delivery of protein\/peptide therapeutics: Strategies and industrial perspectives","volume":"196","author":"Pawar","year":"2014","journal-title":"J Control Release"},{"issue":"1-2","key":"10.1002\/med.21403-BIB0152|med21403-cit-0152","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ijpharm.2006.09.038","article-title":"Chitosan-based controlled porosity osmotic pump for colon-specific delivery system: Screening of formulation variables and in vitro investigation","volume":"332","author":"Liu","year":"2007","journal-title":"Int J Pharm"},{"issue":"1-2","key":"10.1002\/med.21403-BIB0153|med21403-cit-0153","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ijpharm.2012.12.008","article-title":"Hydrogen bond replacement-unearthing a novel molecular mechanism of surface solid dispersion for enhanced solubility of a drug for veterinary use","volume":"441","author":"Singh","year":"2013","journal-title":"Int J Pharm"},{"issue":"1-2","key":"10.1002\/med.21403-BIB0154|med21403-cit-0154","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ejps.2005.12.009","article-title":"Stabilization of solid dispersions of nimodipine and polyethylene glycol 2000","volume":"28","author":"Urbanetz","year":"2006","journal-title":"Eur J Pharm Sci"}],"container-title":["Medicinal Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fmed.21403","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fmed.21403","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/med.21403","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T12:13:47Z","timestamp":1625487227000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/med.21403"}},"subtitle":["POLYMERS AS PHARMACEUTICAL EXCIPIENTS"],"short-title":[],"issued":{"date-parts":[[2016,8,9]]},"references-count":154,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"URL":"https:\/\/doi.org\/10.1002\/med.21403","archive":["Portico"],"relation":{},"ISSN":["0198-6325"],"issn-type":[{"value":"0198-6325","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8,9]]}}}